title: [Long-term tolerance of flupirtine. Open multicenter study over one year].
abstract: METHODS
  To answer the question as to whether the analgesic flupirtine is suitable for long-term treatment of chronic pain, its side effects and efficacy were investigated over a 12-month treatment period. A total of 191 patients with chronic pain of degenerative and/or inflammatory musculoskeletal diseases were admitted to the open, uncontrolled multicenter study. This was followed by a single-blind placebo follow-up period of two weeks aimed at detecting withdrawal phenomena as a sign of a possible addictive potential of flupirtine.
  
  
  RESULTS
  On the basis of patient and investigator documentation, laboratory studies and clinical examinations, flupirtine was found to be both well tolerated and effective. No signs of tolerance, addiction or relevant interactions were observed. The side effect profile differed from that of the opioids or prostaglandin synthesis inhibitors (NSAIDs).
authors.affiliation: Psychiatrische Klinik und Poliklinik, Klinikum Rudolf Virchow, Freie Universität Berlin.
authors.forename: W M
authors.initials: WM
authors.lastname: Herrmann
authors.forename: R
authors.initials: R
authors.lastname: Hiersemenzel
authors.forename: M
authors.initials: M
authors.lastname: Aigner
authors.forename: M
authors.initials: M
authors.lastname: Lobisch
authors.forename: H
authors.initials: H
authors.lastname: Riethmüller-Winzen
authors.forename: I
authors.initials: I
authors.lastname: Michel
mesh_terms: D000328:Adult; D000368:Aged; D000631:Aminopyridines / Q000009:adverse effects / Q000627:therapeutic use*; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009140:Musculoskeletal Diseases / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement
chemical_list: D000631:Aminopyridines; D000700:Analgesics; C034161:flupirtine
vernacular_title: Die Langzeitverträglichkeit von Flupirtin. Offene multizentrische Studie über ein Jahr.